Palisade Bio Inc. (NASDAQ:PALI) went down by -15.94% from its latest closing price compared to the recent 1-year high of $6.79. The company’s stock price has collected -41.19% of loss in the last five trading sessions.
Is It Worth Investing in Palisade Bio Inc. (NASDAQ :PALI) Right Now?
Plus, the 36-month beta value for PALI is at 1.64. Opinions of the stock are interesting as 2 analysts out of 2 who provided ratings for Palisade Bio Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $4.00, which is $3.57 above the current price. PALI currently public float of 13.49M and currently shorts hold a 8.76% ratio of that float. Today, the average trading volume of PALI was 1.61M shares.
PALI’s Market Performance
PALI stocks went down by -41.19% for the week, with a monthly drop of -53.90% and a quarterly performance of -54.97%, while its annual performance rate touched -91.93%. The volatility ratio for the week stands at 18.75% while the volatility levels for the past 30 days are set at 10.17% for Palisade Bio Inc.. The simple moving average for the period of the last 20 days is -47.58% for PALI stocks with a simple moving average of -76.75% for the last 200 days.
PALI Trading at -53.49% from the 50-Day Moving Average
After a stumble in the market that brought PALI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -93.63% of loss for the given period.
Volatility was left at 10.17%, however, over the last 30 days, the volatility rate increased by 18.75%, as shares sank -54.49% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -53.01% lower at present.
During the last 5 trading sessions, PALI fell by -41.19%, which changed the moving average for the period of 200-days by -87.29% in comparison to the 20-day moving average, which settled at $0.7988. In addition, Palisade Bio Inc. saw -66.75% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at PALI starting from Dawson Michael John, who purchase 15,000 shares at the price of $1.14 back on Mar 29. After this action, Dawson Michael John now owns 15,000 shares of Palisade Bio Inc., valued at $17,092 using the latest closing price.
Hallam Thomas, the Chief Executive Officer of Palisade Bio Inc., purchase 10,000 shares at $1.18 during a trade that took place back on Mar 28, which means that Hallam Thomas is holding 17,592 shares at $11,800 based on the most recent closing price.
Stock Fundamentals for PALI
The liquidity ratio also appears to be rather interesting for investors as it stands at 4.96.